Author

Ju RueyJiuan Lee

OpenAlex ID: A5073789192

Clinical Profile of Single-Agent Oprozomib in Patients (Pts) with Multiple Myeloma (MM): Updated Results from a Multicenter, Open-Label, Dose Escalation Phase 1b/2 Study

2014 · Ravi Vij, Michael Savona, et al. · Blood · 31

A Phase 1b Study of 30-Minute Infusion Carfilzomib 20/45 and 20/56 Mg/m2 Plus 40 Mg Weekly Dexamethasone in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma

2012 · Ashraf Z. Badros, Kyriakos P Papadopoulos, et al. · Blood · 16

Updated Results from a Multicenter, Open-Label, Dose-Escalation Phase 1b/2 Study of Single-Agent Oprozomib in Patients with Waldenström Macroglobulinemia (WM)

2014 · David S. Siegel, Jonathan L. Kaufman, et al. · Blood · 14

A Phase 1b Dose-Escalation Study of Split-Dose Oprozomib (ONX0912) in Patients with Hematologic Malignancies

2012 · Michael R. Savona, Jesus G. Berdeja, et al. · Blood · 9

Works count: 4

Citation count: 70

H-index: 4

I10-index: 3